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 ABSTRACT 
 
In the application of the Threshold of Toxicological Concern (TTC) concept to non-cancer endpoints, 
the decision tree proposed by Cramer, Ford and Hall in 1978, commonly referred to as the Cramer 
scheme, is probably the most widely used approach for classifying and ranking chemicals according to 
their expected level of oral systemic toxicity. The decision tree categorises chemicals, mainly on the 
basis of chemical structure and reactivity, into three classes indicating a high (Class III), medium 
(Class II) or low (Class I) level of concern. Each Cramer class is associated with a specified human 
exposure level, below which chemicals are considered to present a negligible risk to human health. In 
the absence of experimental hazard data, these exposure threshold (TTC) values have formed the basis 
of priority setting in the risk assessment process. To facilitate the application of the TTC approach, the 
original Cramer scheme, and an extended version, have been implemented in Toxtree, a freely 
available software tool for predicting toxicological effects and mechanisms of action. Building on 
previous work by Patlewicz and coworkers, this report provides some suggestions for improving the 
Cramer scheme based on a review of the scientific literature, a survey of Toxtree users, and an analysis 
of lists of body and food components incorporated in Toxtree. 
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1. Introduction to the TTC concept and the Cramer decision tree 
1.1 Introduction 
The Threshold of Toxicological Concern (TTC) concept refers to the establishment of a generic oral 
exposure level for (groups of) chemicals below which there is expected to be no appreciable risk to 
human health (Barlow, 2005). The TTC approach is intended for use as a screening tool for chemicals 
for which substance-specific toxicity data are not available or routinely required in regulatory 
submissions, for example metabolites and degradation products. Originally, the approach was used in 
the assessment of indirect food additives (contact substances) and food flavourings; and subsequently, 
it has been investigated and proposed for use in a wide range of regulatory areas. 
To facilitate the consistent and transparent application of the TTC approach, including the assessment 
of both cancer and non-cancer endpoints, the JRC has developed the Toxtree software 
( 1Uhttp://ihcp.jrc.ec.europa.eu/our_labs/computational_toxicology/qsar_tools/toxtreeH), in collaboration 
with various partners, including IdeaConsult Ltd (Bulgaria), Curios-IT (The Netherlands) and the 
Istituto di Sanita’ (Italy). The most widely used TTC approach for non-cancer endpoints is the Cramer 
decision tree, developed by Cramer, Ford and Hall in 1978 (Cramer et al, 1978). An initial evaluation 
of the Toxtree implementation of the Cramer scheme was carried out by Patlewicz and coworkers 
(2008), and this led to several recommendations for improving the Cramer scheme and its 
computational interpretation in Toxtree. 
This paper summarises additional findings and observations on the Cramer scheme, based on a 
literature review and on a survey of Toxtree users. The survey was carried out in collaboration with the 
European Food Safety Authority (EFSA) and the results were used to support the development of an 
EFSA Opinion on the applicability of TTC in the food and feed safety area (EFSA, 2011).  
1.2 Cramer decision tree 
In the application of the TTC concept to non-cancer endpoints, the Cramer decision tree is probably 
the most commonly used approach for classifying and ranking chemicals on the basis of their expected 
level of oral toxicity. It was proposed by Cramer, Ford and Hall in 1978 (Cramer et al, 1978) as a 
priority setting tool in the safety assessment of food additives which would make expert judgements 
more transparent, explicit and rational, and thus more reproducible and trustworthy. The scheme was 
derived from the authors’ earlier experience in classifying food flavours (Oser & Hall, 1977) and their 
subsequent work in evaluating a range of carcinogens, pesticides and industrial chemicals (Cramer et 
al, 1978).  
The original Cramer decision tree  consists of 33 questions, each answered 'yes' or 'no' and leading to 
another question or to the final classification into one of the three classes (I, II and III) as follows: 
 
Class I Substances with simple chemical structures and for which efficient modes of 
metabolism exist, suggesting a low order of oral toxicity.  
Class II  Substances which possess structures that are less innocuous than class I substances, but 
do not contain structural features suggestive of toxicity like those substances in class 
III. 
Class III Substances with chemical structures that permit no strong initial presumption of safety 
or may even suggest significant toxicity or have reactive functional groups. 
 
The logic of the sequential questions (Figure 1) was based on the then available knowledge on toxicity 
and on how chemical structures were metabolised in mammalian metabolic pathways. The questions 
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relate mostly to chemical structure, but natural occurrence in the body (Q1) and in food (Q22) are also 
taken into consideration (Table 1). The tree is intended for use with all ingested, structurally defined 
organic and metallo-organic substances.  
 
The Cramer scheme was tested against 81 chemicals including pesticides, drugs, food additives and 
industrial chemicals with known no observed effect level (NOEL) values reported in terms of dietary 
concentrations in short-terms or chronic studies (Cramer et al. 1978). Although there was overlap in 
the range of magnitudes of the NOELs between the three structural classes, it was clear that the 
NOELs of Class I substances were generally higher than those of Class III, with those of Class II being 
in between. Noteworthy, there was no underestimation of toxicity when compared with the available 
chronic oral toxicity data. 
 
1.3 Derivation of human exposure threshold values 
The Cramer decision tree was subsequently used by Munro and coworkers with the purpose of 
deriving human exposure levels (TTC values) for toxicity endpoints other than carcinogenicity (Munro 
et al., 1996). The Munro dataset comprised over 613 organic chemicals with associated 2941 NOEL 
values derived from a variety of non-cancer endpoints from sub-chronic, chronic, reproductive and 
developmental toxicity studies carried out in rodents and rabbits. The authors assigned the dataset 
substances to one of the three classes based on the Cramer scheme, and derived human exposure 
threshold values by taking the lower fifth percentile value of the distribution of NOELs for each of the 
three Cramer classes, multiplying by 60 to convert the values expressed as mg/kg bw per day into 
mg/person per day, and then dividing by a factor of 100 to ensure a margin of safety. On this basis, 
Munro and coworkers proposed TTC values of 1800, 540 and 90 μg/person/day for class I, II and III, 
respectively. 
 
In addition to the above-mentioned TTC levels for non-cancer endpoints, specific (and lower) TTC 
levels have also been derived for compounds with structural alerts for genotoxicity (0.15 μg/day) and 
for organophosphates (18 μg/day) (Kroes et al., 2004), the general idea being that these lower 
threshold values should be applied in a tiered assessment approach before the Munro non-cancer 
threshold values. 
 
The TTC levels proposed by Munro are now widely used in the food safety area, for example in the 
international evaluation of flavouring substances (first applied by the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) in 1997 [WHO, 1997]) 
 
1.4 Investigations on the applicability of the TTC approach 
Application of the TTC approach requires knowledge of the chemical structure of the substance 
concerned as well as information on human exposure. It is intended for use as a screening tool for 
chemicals for which substance-specific toxicity data are not available. At present, the approach is used 
in the EU (EFSA) and internationally (JECFA) in the evaluation of flavouring substances in food, and 
is also used in the EU in the evaluation of pesticide metabolites in groundwater (SCP, 2000). 
 
In addition, the approach has been investigated for its possible application in a wide range regulatory 
areas, including environmental risk assessment (De Wolf et al., 2005), consumer products (Blackburn 
et al. 2005), cosmetics (Kroes et al., 2007), impurities in pharmaceutical preparations (Müller et al. 
2006) and plant-protection product metabolites (Melching-Kollmuß et al. 2010; CRD 2010). 
 
There is also considerable ongoing research. For example, the ILSI Research Foundation 
( 1Uhttp://www.ilsi.org/ResearchFoundation/H) is working with the US EPA and the biocides industry on of 
the application of the TTC approach to antimicrobial pesticides. Within the EU-funded COSMOS 
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project (1Uhttp://www.cosmostox.eu/H), the applicability of current and novel classification schemes to 
cosmetics is being explored. 
 
 
Figure 1. Decision tree of the Toxtree - Cramer scheme (original) plug-in. Yes branch in green. No 
branch in red. Terminal nodes (labelled 1, 2 & 3) refer to Cramer classifications I, II and III. 
 
 
 
 
Figure 2. Decision tree of the Toxtree - Cramer scheme with extensions plug-in. Yes branch in green. No 
branch in red. Terminal nodes (labelled 1, 2 & 3) refer to Cramer classifications I, II and III. 
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Table 1. Questions of the Cramer decision tree: the original scheme (Q1-33) and the extended 
scheme (Q40-44) as implemented in the Toxtree software 
 
Question 
No. 
Question title If YES,  
assign label 
If YES, 
go to rule 
If NO,  
assign label 
If NO,  
go to rule 
1 Normal constituent of the body 
Low  
(Class I) 
    2 
2 Contains functional groups associated 
with enhanced toxicity 
High 
(Class III) 
    3 
3 Contains elements other than 
C,H,O,N,divalent S   4   43 
4 Elements not listed in Q3 occurs only as a 
Na,K,Ca,Mg,N salt, sulphamate, 
sulphonate, sulphate, hydrochloride ... 
  40 
High  
(Class III) 
  
40 Possibly harmful organophosphate or 
organophosphothionate... 
High  
(Class III) 
    41 
41 Removes phosphates 
Low 
(Class I) 
    7 
7 Heterocyclic   8   16 
8 Lactone or cyclic diester   9   10 
9 Lactone, fused to another ring, or 5- or 6-
membered α,β-unsaturated lactone? 
High  
(Class III) 
    
[Open 
chain] 
[Open 
chain] Open chain   20   
[Hetero- 
cyclic] 
20 Aliphatic with some functional groups 
(see explanation)   21   22 
21 3 or more different functional groups 
High 
(Class III) 
    44 
44 Free α,β-unsaturated heteroatom... 
High  
(Class III) 
    18 
18 One of the list (see explanation) 
Intermediate  
(Class II) 
  
Low  
(Class I) 
  
22 Common component of food 
Intermediate  
(Class II) 
    33 
33 Has sufficient number of sulphonate or 
sulphamate groups 
Low  
(Class I) 
  
High  
(Class III) 
  
[Hetero- 
cyclic] Heterocyclic 
  10   23 
10 3-membered heterocycle 
High  
(Class III) 
    11 
11 Has a heterocyclic ring with complex 
substituents.   33   12 
12 Heteroaromatic   13   22 
13 Does the ring bear any substituents?   14 
High  
(Class III) 
  
14 More than one aromatic ring   15   22 
15 Readily hydrolysed   [Heterocyclic]   33 
[Hetero- 
cyclic] Heterocyclic   22 
  16 
16 
Common terpene 
Low 
(Class I) 
    17 
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Question 
No. 
Question title If YES,  
assign label 
If YES, 
go to rule 
If NO,  
assign label 
If NO,  
go to rule 
17 Readily hydrolysed to a common terpene   [Terpene]   19 
[Terpene] Common terpene   18   19 
19 Open chain   20   23 
23 Aromatic   27   24 
27 Rings with substituents   28 
High 
(Class III) 
  
28 More than one aromatic ring   29   30 
29 Readily hydrolised   [Aromatic]   33 
[Aromatic] Aromatic   30   19 
30 Aromatic Ring with complex substituents   31   [Aromatic] 
31 Is the substance an acyclic acetal or ester 
of substances defined in Q30?   [Aromatic]   32 
[Aromatic] Aromatic   18   19 
32 Contains only the functional groups listed 
in Q30 or Q31 and those listed below. 
Intermediate  
(Class II) 
    22 
24 Monocarbocyclic with simple substituents   18   25 
25 
Cyclopropane, … 
Intermediate  
(Class II) 
    26 
26 Monocycloalkanone or a 
bicyclocompound 
Intermediate  
(Class II) 
    22 
43 Possibly harmful divalent sulphur (not 
detected via Q3)... High (Class III)     5 
5 Simply branched aliphatic hydrocarbon or 
a common carbohydrate Low (Class I)     6 
6 Benzene derivative with certain 
substituents High (Class III)     42 
42 Possibly harmful analogue of benzene... High (Class III)     7 
Questions 40-44 (number underlined) are part of the extended version of the Cramer decision tree scheme. The ‘Cramer rules with 
extensions’ plug-in was developed by Curios-IT, The Netherlands, on behalf of the JRC. 
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2. Computer-based implementation of the Cramer decision tree 
While the Cramer classification scheme undoubtedly served to improve consistency between the 
toxicological evaluations made by different experts, its paper-based application presupposes a working 
knowledge of organic chemistry and biochemistry, as the rulebase relies primarily on features of 
chemical structure, chemical reactivity, toxicity and metabolism, and inevitably involves a degree of 
subjectivity. Therefore, following a recommendation made in a JRC workshop (Saliner et al, 2005), 
the JRC commissioned the development of a software tool, Toxtree, to facilitate the consistent 
application of the Cramer scheme. Toxtree is an open-source software and is freely downloadable from 
the JRC website (2Uhttp://ihcp.jrc.ec.europa.eu/our_labs/computational_toxicology/qsar_tools/toxtreeH) 
and from the sourceforge.net site: (2Uhttp://toxtree.sourceforge.net/H). The Toxtree implementation of the 
Cramer scheme can, in principle, be applied to organic molecules, organic salts and organometallics, 
and structurally well-defined oligomers and polymers. However, there are some scientifically 
motivated exclusions to the use of Cramer scheme due to insufficient data in the underlying TTC 
datasets (EFSA, 2011). 
 
It should be noted that the computer-based implementation of the Cramer scheme in Toxtree and other 
software tools (e.g. OECD QSAR Toolbox) has inevitably involved some decisions by the 
programmer, such as the chemically-based interpretation of the original rules, and the establishment of 
pre-defined “look-up lists” of normal body constituents and common food components. The 
performance of the Cramer scheme in Toxtree has been evaluated by Patlewicz et al. (2008).  
 
Toxtree (v. 2.1.0 and later) includes three rulebases relevant to TTC assessment: 1) the Cramer 
decision tree (Figure 1) as described in the original paper (Cramer et al., 1978); 2) the Cramer rulebase 
with extensions (Figure 2); and 3) the TTC decision tree by Kroes et al. (2004). Table 1 lists the 
questions and the architecture of the Cramer scheme (including extensions).  
 
The Extended Cramer rulebase was introduced in 2009 to overcome possible misclassifications of 
several compounds which, following the Cramer decision tree scheme, were classified as Class I or 
Class II by Munro et al. (1996) even though the authors reported low NOEL values upon oral 
administration (indicating relatively high toxicity). The extended Cramer rulebase works by assigning 
compounds to Class I, II, or III, according to the original Cramer rules (questions 1-33) and five extra 
ones (questions 40-44). Also, the extended Cramer rulebase has an expanded list of natural body 
constituents for question 1 (over 400 unique compounds, with no hormones) with respect to the 
original Cramer scheme plug-in (67 compounds), in line with Cramer’s assumption that, with the 
exclusion of hormones, human endogenous compounds pose a minor risk to health (Cramer et al., 
1978). 
 
The TTC decision tree by Kroes et al. (2004) results in three possible outcomes: a) substance would 
not be expected to be a safety concern; b) negligible risk (low probability of a life-time cancer risk 
greater than 1 in 106); and c) risk assessment requires compound-specific data. It incorporates the 
Benigni/Bossa rules for the identification of genotoxic carcinogens (Benigni et al., 2008), and requires 
the user to input the estimated daily intake. 
 
Toxtree provides a convenient computer-based and consistent means of applying the Cramer scheme 
(and related rulebases), which was developed in the pre-computational era. Any discrepancy between 
the Toxtree classification and the expected Cramer assignment can be traced to a specific rule by 
examining the Toxtree pathway (this is termed the "verbose explanation" appearing in the 'reasoning' 
window of the software main screen), which gives the answer to each question followed by the final 
classification (e.g. 1N, 2N, 3Y, 4N – Class III). 
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3. Survey on the Cramer decision tree in Toxtree 
As the Cramer scheme in Toxtree is being increasingly used, particularly by industry and regulatory 
bodies, it was decided to further evaluate its scope and limitations in relation to the TTC approach.  
 
We carried out a survey in the form of a structured questionnaire to Toxtree users, with a view to: a) 
identifying decision rules for which clarification was needed; b) obtaining recommendations to revise, 
remove or add a given rule; and c) identifying bugs or inconsistencies in the Toxtree implementation 
of the Cramer rulebase. The questionnaire is reported in Appendix 1. The comments received and 
recommended follow-up actions are summarised in Appendix 2. 
 
Although a relatively small number of completed questionnaires were returned (5 replies out of 12 
recipients), most responders provided detailed comments and raised additional questions on specific 
issues related to interpretation of the Cramer scheme and the classification results they obtained with 
given test compounds.  
 
According to the results of the questionnaire, the Cramer scheme is currently being used in the 
evaluation of trace drinking water contaminants, flavouring substances, migrants from packaging 
materials and excipients and impurities (including leachables and extractables) in drug products or 
personal and household care products. The main observations concerning the scientific refinement of 
the Cramer scheme can be summarised as follows: 
 
1) Many of the original Cramer rules are written in a confusing and inter-dependent way, which 
leads to difficulties in the rationalisation of the predictions they make. These rules should be 
rewritten in a clearer way, possibly with modification and re-ordering. 
 
2) Two rules are not based on chemical features, but simply make reference to look-up lists of 
chemicals (Q1, normal body constituents; Q22, common food components). The Cramer 
scheme should be revised by removing these two questions. The use of look-up lists to assess 
whether specified substances can be regarded as “safe” (or even “unsafe”) should be carried out 
separately (outside of the Cramer scheme per se), as part of the overall the TTC assessment 
scheme. These look-up lists can be adapted (i.e. extended, reduced or even not used by a given 
regulatory body) based on expert knowledge and experience. Ideally, the lists should be subject 
to regulatory peer-review. 
 
3) Some rules make ambiguous references to chemical features (e.g. steric hindrance) which need 
to be clarified and possibly revised/deleted. 
 
4) The Cramer rulebase with extensions (which already contains an expanded list for Q1) does not 
appear to be widely used. 
 
5) Several studies (e.g. Appendix 3) have identified outliers in the Cramer classification scheme, 
for example Class I outliers that have low NOELs). These outliers should be taken into account 
in any revisions to the Cramer scheme, with a view to making the classification scheme more 
discrminating in terms of NOEL values.  
 
6) It might be desirable to establish an international forum for agreeing changes to the Cramer 
scheme.  
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4. Analysis of the look-up lists for common body and food components 
The Toxtree user manual refers to look-up lists of common body and food components as follows:   
 
“Cramer rules #1 and #22 depend explicitly on user-defined lists of compounds, which are 
normal constituents of the body or common components of food. We provide example lists of 
such compounds in the files bodymol.sdf and foodmol.sdf respectively… Please, note that the 
bodymol.sdf and foodmol.sdf files are provided mainly as an example. They contain currently 
only a very limited number of “Normal constituents of the body” and “Common components 
of food” respectively, following an expert advice. Users should consider expanding these 
files with appropriate molecules.” 
 
Since some of the comments received in the survey recommended that the look-up lists of common 
body and food components should be excluded from the Cramer scheme, we decided to explore how 
the Cramer scheme would classify these substances if the look-up lists (bodymol and foodmol) were 
not taken into account. This was carried out by processing the bodymol and foodmol structures in 
Toxtree, using both the unmodified form of the Cramer rulebase, and a modified form in which the 
look-up files were replaced with empty (structure-free) files. The method and results are described in 
more detail in Appendix 4. 
 
A total of 548 compounds, including 440 bodymol and 108 foodmol compounds, were analysed. The 
results show that a high proportion (75%; 409 out of 548) of the compounds in the look-up lists are 
potentially of medium (Class II) or high (Class III) concern as classified by the Toxtree 1.6 - Cramer 
with extensions plug-in (modified, without look up lists), whereas 139 compounds (25%) are of low 
concern. Of the 409 compounds classified in Cramer Classes II or III, 114 compounds are predicted as 
genotoxic by the Benigni-Bossa module for carcinogenicity and mutagenicity (Benigni et al, 2008). 
Thus, in the context of an overall TTC assessment scheme, such as the Kroes decision tree (Kroes et 
al. 2004), these 114 compounds would be removed in a pre-Cramer step, and would therefore not 
receive a Cramer classification. In addition, the Benigni-Bossa rulebase also predicts 10 of 139 Cramer 
Class I compounds as genotoxic. The pre-screening by the Benigni-Bossa rulebase would therefore 
result in124 compounds being removed from further consideration, while 424 compounds would enter 
the Cramer scheme.  
5. Concluding remarks and recommendations 
The Cramer scheme was proposed in the late 1970s, before the development of what is now 
understood by the TTC approach and before the advent of computer-based tools for interpreting 
chemical structure and applying structure-activity relationships. Subsequently, in the 1990s, Munro 
and colleagues proposed the association between Cramer classes I, II and III and human exposure 
thresholds for non-cancer endpoints of 1800, 540 and 90 μg/person/day, respectively (Section 1.3). On 
the basis of various independent analyses, using different datasets and endpoints of concern, these 
threshold values have been found to be robust and protective for human health (EFSA, 2011). 
Nevertheless, an alternative set of threshold values could be derived on the basis of a more extensive 
toxicity database and a classification scheme reflecting current knowledge of toxicity and metabolism, 
and incorporating structural features identified by modern structure-activity modelling tools.   
 
Despite its practical applicability in protecting human health, the Cramer scheme has a number of 
scientific limitations, namely: a) it is dated, being based on the knowledge of the late 1970s; b) there is 
considerable overlap in the NOEL distributions of the three classes, which means that the Cramer 
classes do not discriminate well between substances of different toxic potencies; and c) Cramer Class 
II is ill-defined and sparsely populated for most chemical types, and thus of questionable added value.  
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In the short-term, it is recommended that the Cramer scheme should be rewritten, making it more 
transparent and easy-to-understand. Such an exercise should take into account the rules that work well, 
but also make changes (rule additions, rule deletions, revisions in rule scope and ordering, where 
necessary). In re-writing the Cramer scheme, it may be sufficient to include only two classes, 
corresponding to high and low concern, where the high concern class corresponds to current Cramer 
classes II and III. Lists of “safe” or “unsafe” substances should not be part of the scheme. Thus, the 
bodymol and foodmol lists of common endogenous body components and food ingredients should be 
inactivated.  
In the longer term, the Cramer scheme should be significantly rewritten / abandoned in favour of a 
purely structure-based classification scheme that takes into account current research based on the use 
of multivariate statistical and data-mining methods to uncover new structural features that may be 
useful in setting human exposure thresholds. Some preliminary investigations in this direction have 
been published (e.g. Bassan et al, 2011). Again, lists of “safe” or “unsafe” substances should not be 
part of the non-cancer classification scheme, but should be considered as part of the overall TTC 
assessment scheme. Similarly, the inclusion of additional thresholds relating to (genotoxic) 
carcinogens and other endpoints of high concern (e.g. neurotoxicity) should be part of the overall TTC 
assessment scheme.  
Finally, given the considerable international interest in the use of the Cramer decision tree, it would be 
desirable to establish an international platform to discuss and agree changes to the Cramer scheme, 
which would then form the basis for new plug-ins to the Toxtree software. 
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8. Appendices 
Appendix 1. Questionnaire on the use of Toxtree Cramer 
 
The Cramer classification scheme is implemented as a rulebase in Toxtree, a standalone software application 
which is downloadable from the Joint Research Centre (JRC) website.  
The aim of this questionnaire is to gain an overview of how the Toxtree – Cramer rulebase is being used in 
decision making, to develop better guidance on its application, and to guide the further development of the 
software.  
The information provided will also be used in the drafting of an European Food Safety Authority (EFSA) 
Opinion on the applicability of the TTC concept in food safety assessment. Please feel free to forward the 
questionnaire to interested persons. 
Please e-mail the completed form to:  Dr Silvia Lapenna, EC Joint Research Centre 
E-mail: 2Usilvia.lapenna@ec.europa.eu 
 
Question Answer 
  
1) Please provide your name and organisation, or 
indicate that you wish your responses to be kept 
anonymous. 
 
2) For what purpose(s) do you (or does your 
organisation) use the Cramer scheme (e.g. what kinds of 
compounds and in which regulatory context)? 
 
3) Have you encountered examples of chemicals for 
which the Toxtree interpretation of a specific rule or set 
of rules was in disagreement with your knowledge 
and/or when the Toxtree output (Cramer class) was 
contrary to your expectation? If yes, please give the 
chemical name and structure, and describe the 
discrepancy. 
 
4) How do you assess “difficult” substances such as 
salts, metallic compounds, and polymers using Toxtree? 
  
5) Have you ever used the extended Cramer scheme 
which is available as a Toxtree plug-in? 
 
6) Have you encountered any software problems, such 
as bugs or processing errors, while working with the 
Toxtree? If yes, please specify. 
 
7) Do you have any general suggestions on how Toxtree 
could be improved (not limited to the Cramer rulebase)? 
 
8) Do you have any suggestions on how the Cramer 
scheme (as opposed to Toxtree) could be improved?  
 
9) Please add any additional comments or suggestions 
here. 
 
10) Please indicate if any information provided above 
cannot be shared outside the JRC.   
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Appendix 2. Comments / observations on Cramer rulebase and its Toxtree implementation 
 
Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
Q1 Is the substance a normal constituent of the 
body, or an optical isomer of such?  
The look-up list could be extended 
(Patlewicz et al. 2008). Alternatively, 
the look-up list could be removed from 
the Cramer decision tree scheme, and 
considered separately as additional 
information (JRC observation). 
Rulebase + software 
The list of normal body constituents (bodymol.sdf file) contains 68 
compounds (original Cramer) and 440 compounds (Cramer with 
extensions).  
  Some of the listed natural body 
constituents may pose toxicity concerns 
and should not be classified as 'low 
concern' substances, e.g. potent 
receptor binders or their precursors 
(e.g. dopamine, L-dopa, tyramine), 
prostaglandin-H2, and reactive species 
(e.g. H2O2).  
 
It was found that 352 out of 440 
chemicals on the bodymol list would 
trigger a class II or III classification, if 
they were not treated as class I because 
they are constituents of the body.  
Rulebase + software 
1) Remove any chemical look-up lists from the Cramer classification 
scheme (Q1 and Q22), as inconsistent with the remainder of the scheme, 
which is based on structure or reactivity (hydrolysis/metabolism). In this 
way, toxicity classification will result only from its chemical structure 
and its biokinetics. 
2) Keep these lists as supplementary information in the context of the 
overall TTC evaluation. 
 
 
  The JECFA Cramer Classification of 
flavouring substances often differs 
from the output of Toxtree, mainly 
because of differences regarding their 
qualification as natural body 
constituents   
Rulebase + software 
Obtain lists of flavouring substances and check against the bodymol file.  
Q2 Does the substance contain any of the 
following functional groups associated with 
enhanced toxicity:  
an aliphatic secondary amine or a salt 
thereof, cyano, N-nitroso, diazo, triazeno or 
quaternary nitrogen, except in any of the 
following forms: >C=N+R2, >C=N+H2 or 
the hydrochloride or sulphate salt of a 
- - 
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
primary or tertiary amine?  
Q3 Does the structure contain elements other 
than C, H, O, N or divalent S?  
Examples from EFSA: 
In the following molecules,  the S in 
aromatic ring is not recognised as 
divalent: 
O=C(C1=C(SN=N2)C2=CC=C1)SC   
 
O=C(O)N[C@H](C(N[C@@H](C1=NC2=
CC=C(F)C=C2S1)C)=O)C(C)C 
 
C1(C2=CSC=N2)=NC3=CC=CC=C3N1 
Answer to Q3 was found to be wrong: it is a divalent S even if it is part 
of an aromatic ring. On the other hand, answer to Q3 is correct when you 
run an unsaturated ring containing S (divalent). 
This problem has been fixed in Toxtree v. 2.1.0 and later, by replacing 
valency calculation based on CDK atom typing, instead of 
counting bond order (1.5 for aromatic bonds). 
 
 
Q43 Does the compound contain a non-natural 
divalent sulphur (not detected via Q3)?  
- - 
Q4 Do all elements not listed in Q3 occur only 
as  
(a) a Na,K,Ca,Mg or N salt of a carboxylic 
acid, or  
(b) a sulphate or hydrochloride of an amine, 
or 
(c) a Na,K, or Ca sulphonate, sulphamate or 
sulphate?  
Q4 does not list phosphates 
Examples by Patlewicz (predicted 
classs II instead of I): 
disodium 5’ guanylate  
disodium 5-inosate 
sodium steroyl lactate 
[Na+].O=C(OC(C)C(=O)OC(C)C(O)=
O)CCCCCCCCCCCCCCCCC 
 
Rulebase + Clarification 
Because Q4 does not list phosphate salts (in the original Cramer scheme 
and in Toxtree-Cramer scheme), any compound with a P element is 
assigned as Class III.  
However, this causes many safe natural compounds / known food 
additives to be misclassified as higher concern.  
To solve this, Q4 has been changed (and Q40 added) in the extended 
Cramer scheme plug-in (see below). 
Q4 (in 
Cramer 
rules with 
extension
s plug-in) 
 Q4 should include phosphates, but not 
other organophosphoro derivatives. 
 
Rulebase + Clarification (in Cramer rules with extensions plug-in only) 
In the base Cramer scheme, Q4 classifies any compound with a P as 
Class III. However, it is known that many compounds with phosphates 
occur in natural compounds. To enable fewer false positive class III 
predictions, the Cramer scheme with extensions plug-in was developed. 
However, it was shown not to be implemented correctly. The correct 
implementation is as follows: 
1) Q4 of the extended Cramer tree should be revised to allow Phosphorus 
elements too to proceed to Q40, i.e. answer “Yes” to compounds that 
contain no other possibly harmful group than a P. 
2) Q40 should filter out compounds with dangerous P group, i.e. 
uncharged organophosphate, phosphonates, phosphamates, 
phospohoroamido, and hydroxymethylphosphinyl derivatives. In other 
words, Q40 should consider any P that is not part of a negatively charged 
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
phosphate as "Yes" =>High/Class III 
 
The phrasing of Q4 of the extended Cramer tree should be updated 
accordingly, i.e. to allow Phosphorus elements too (of which risky ones 
are filtered successively by Q40). 
  Examples of misprediction reported by 
EFSA: 
P(CC1=CC(C(C)(C)C)=C(O)C(C(C)(C
)C)=C1)(OCC)=O.[O-
]P(CC2=CC(C(C)(C)C)=C(O)C(C(C)(
C)C)=C2)(OCC)=O.[Ca+2] 
Answer to Q4 is No, resulting in class 
III while should be Yes, as it contains 
Ca, and proceed to the next question 
Software 
Q40 Is any element not listed in Q3 an 
uncharged organophosphate  
 
Recognises possibly harmful (uncharged) 
organophosphate or organophosphothionate 
and put it to class III (but let charged PO4 
through Q41) 
Unclear rule 
 
 
  
Clarification 
e.g. add phosphoric triamides  O=P(N(C)C)(N(C)C)N(C)C, as these are 
Q40Y. 
Rulebase: investigate mispredictions for possible rule refinement 
 
Q41 All phosphate groups that can occur in 
natural compounds are hydrolysed and 
removed.  Each resulting fragment 
considered individually in the tree 
Unclear rule? What does “hydrolysed 
and removed” mean? (EFSA 
observation) 
 
Clarification 
Unlike most Cramer questions, Q41 is not a yes/no question. Instead, 
Q41 only splits any natural phosphate-like moiety from the molecule 
and: 1) removes the phosphates (PO4) from the compound, and 2) puts 
the remaining fragments through the rest of the tree via the “answer” 
“No” (via Q7), one by one (Residue 1, 2, etc.). 
  In the example “No” (see the structure 
below), which kind of Phosphorus are 
you considering? (EFSA observation) 
 
 
 
Clarification 
This example is indeed confusing as this compound would actually  
not reach Q41, as Q40 would classify such a compound as class 
III. 
A better example is needed to illustrate a compounds that lacks a 
synthetic/natural phosphate. 
Q5 Is it a simply branched acyclic aliphatic Misclassifcation of sucrose 
monopalmiate and monsterate as class 
Rulebase  
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
hydrocarbon or a common carbohydrate? II instead of I (Patlewicz et al. 2008). 
 
Reinterpretation of “simply branched”? 
Ambiguity of common carbohydrate? 
Q6 Is the substance a benzene derivative 
bearing substituents consisting only of: 
(a) hydrocarbon chains or 1'hydroxy or 
hydroxy ester-substituted hydrocarbon 
chains and  
(b) one or more alkoxy groups, one of 
which must be para to the hydrocarbon 
chain in (a)?  
This places in class III safrole, myristicin 
and related substances. 
- - 
Q42 Does the compound consist of one aromatic 
ring, with at most one heavy atom 
connected to each aromatic atom?  
 
Assigns compounds that consist of a single 
aromatic ring with zero to six single atom-
substituents as Class III. 
Concerns over inclusion of 
monomethylated benzenes 
 
 
Rulebase  
On the (non)toxicity of, say, toluene: while Munro handled a NOEL 
value of 500 mg/kg/day for toluene, lower values have also been 
proposed (e.g. <150 mg/kg/day by Wilkins-Haug L.Teratology. 
1997;55(2):145-51). The rule can be rewritten such that only small 
phenols are captured. 
Q7 Is the substance heterocyclic?  
 
- - 
Q8 Is it a lactone or cyclic diester?  
 
Separates the lactones and cyclic diesters 
from other heterocyclic compounds 
There should be no restriction to 5- and 
6-membered rings for lactones in Q8 in 
Toxtree 
Software 
This was recognised as a bug and fixed in Toxtree v. 2.1.0 and later. 
Q9  Discrepancy (JRC observation) 
 
The 4-membered saturated lactone 
(C1OC(=O)C1C) used as the Yes Class 
III actually gives No and Class I 
This inconsistency is also in the 
original Cramer paper 
Software and possible rulebase revision 
Need to better define this rule – what about 4-membered lactones? 
Q10 Is it a 3-membered heterocycle? 
This places substances like epoxides and 
ethylenamine in class III 
- - 
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
Q11 Does it have a heterocyclic ring with 
complex substituents? 
Disregarding only the heteroatoms on any 
one ring, does that heterocyclic ring contain 
or bear substituents other than simply 
branched (class I) hydrocarbons (including 
bridged chains and monocyclic aryl or alkyl 
structures),alkyl alcohols, 
aldehydes,acetals,ketones,ketals,acids,ester
s (including cyclic esters other than 
lactones),mercaptans, sulphides, methyl 
ethers, hydroxy or single rings (hetero or 
aryl) with no substituents other than those 
just listed?  
Questions 11-15 separate out various 
categories of heteroaromatic substances. 
Under 11, set aside and do not consider the 
atom(s), usually O,N and S, making the 
ring heterocyclic.If there is more than one 
hetero ring, regard each ring separately, 
with the remainder of the structure as 
substituents of that hetero ring.Other than 
the heterocyclic atoms, does the ring carry 
anything besides the simple groups listed?  
If so, the answer is YES,and the next 
question 33. If not, then classify further by 
Q12 etc. Bridged chain derivatives may be 
represented by structures like the bicyclic 
ether 1,4 cineole while monocyclic aryl 
derivatives may be represented by 
compounds like benzaldehyde propylene 
glycol acetal or 3-phenyl-2-
furancarboxaldehyde.  
Incorrect classification of caffeine as 
class III instead of class II (Patlewicz et 
al. 2008). 
Rulebase 
Reconsider scope of question 11 
 
Q12 This question separates the aromatic 
heterocyclics for the purpose of considering 
whether they are polynuclear (Q14) or 
unsubstituted (Q13).  
- - 
Q13 Does the ring bear any substituents?  - - 
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
Q14 Does the structure contain more than one 
aromatic ring?  
- - 
Q15 Is it readily hydrolysed to mononuclear 
residues?If YES, treat the mononuclear 
heterocylic residues by Q.22 and any 
carbocyclic residue by Q16.  
- - 
Q16 Is it a common terpene - hydrocarbon, 
alcohol, aldehyde or -carboxylic acid (not a 
ketone)?  
Q16 and Q17 deal with terpenes. A 
hydrocarbon terpene that is a common 
terpene and has not already been put in 
class I by Q5, would go into class I by Q16. 
- - 
Q17 Is the substance readily hydrolysed  to a 
common terpene -alcohol, aldehyde or 
carboxylic acid?  
If the answer is YES, treat the hydrolysed 
residues separately and proceed to Q18 for 
the terpene moiety and to Q19 for any non-
terpenoid moiety).  
Since there may be substances that are 
hydrolysed to two or more residues, one of 
which is terpene, treat the residues 
separately from Q18 onward.  
Recognition of terpenes could be 
refined (Patlewicz et al. 2008). 
e.g. isobornylacetate 
(O=C(OC1CC2CCC1(C)C2(C)(C))C) 
predicted as class I instead of II, since 
it is  incorrectly assumed to be readily 
hydrolysed  
 Software 
Q18 Is the substance one of the following:  
(a) a vicinal diketone; or a ketone or ketal 
of a ketone attached to a terminal vynil 
group  
(b) a secondary alcohol or ester of a 
secondary alcohol attached to a terminal 
vinyl group  
(c) allyl alcohol or its acetal, ketal or ester 
derivative  
(d) allyl mercaptan, an allyl sulphide, an 
allyl thioester or allyl amine  
(e) acrolein, a methacrolein or ther acetals  
Why are acrylate esters in Class I but 
acrylic acid is in class II (acrylic acid is 
specifically assigned to CC II in the 
Cramer et al publication). 
Clarification and possible rulebase revision 
 
If you use the Cramer rules with extensions, the estimates for acrylate 
esters and acrylic acid are Class III. This is because Q44 recognises a 
small moiety that correlates with low NOELs and false class I/II 
predictions (an alpha,beta-unsaturated heteroatom moiety) and assigns 
such compounds as Class III. 
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
(f) acrylic or methacrylic acid  
(g) an acetylenic compound  
(h) an acyclic aliphatic ketone,ketal or 
ketoalcohol with no other functional groups 
and with four or more carbons on either 
side of the keto group  
(i) a substance in which the functional 
groups are all sterically hindered  
 
Q18 examines the terpenes and later the 
open-chain and mononuclear substances by 
reference) to determine whether they 
contain certain structural features generally 
thought to be associated with some 
enhanced toxicity.  
Q44 Does the compound contain a free 
alpha,beta-unsaturated functional group? 
 
The functional group consists of a carbon 
with an attached heteroatom (O in case of 
an alcohol or ester). Here, 'free' means that 
position beta from this group contains an 
sp2 [CH2] or an sp1 [CH].  
Unclear rule 
Questionable predictions with acrylic 
acid, methacrylic acid and their esters 
 
Clarification and possible rulebase revision and software implementation 
 
Need to further explain how Q44 works and check its implementation. 
Q44 looks for a substructure pattern that can be simplified to 
[CH2]=C~C~O where ~ means any bond. This pattern [CH2]=C~C~O 
matches [CH2]CC=O and/or [CH2]CCO. 
Check with test set including phthalate esters, e.g. diallyl phthalate 
(NOEL = 150mg/kg/day). 
Q19 Is the substance open chain?  
Q19-21 deal with open-chain substances.  
 
- - 
Q20 Is the structure a linear or simply branched 
aliphatic compound, containing any one or 
combination of only the following 
functional groups :  
(a) four or less, each, of alcohol, aldehyde, 
carboxylic acid or esters and/or  
(b) one each of one or more of the 
following: acetal, either ketone or ketal but 
not both, mercaptan, sulphide (mono- or 
poly-), thioester, polyoxyethylene [(-
Difficult to interpret 
Incorrect classification of propargyl 
alcohol as class III instead of class II 
Rulebase 
Need to reconsider the scope of this rule, or even break it down into 
multiple rules 
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
OCH2CH2-)x with x = 4], or primary or 
tertiary amine  
This question should be answered YES if 
the structure contains one or any possible 
combination of alcoholic, aldehydic or 
carboxylic acid or ester groups, provided 
there are no more than four of any one 
kind. 
It should be answered YES if the structure 
contains in addition to, or instead of, those 
just listed, any assortment of no more than 
one each of the following:acetal, either 
ketone or ketal but not both, mercaptan, 
mono- or polysulphide, thioester, 
polyoxyethylene, primary or tertiary amine. 
Answer the question NO if the structure 
contains more than four of any of the first 
set of groups, more than one of the second 
set, or any substituent not listed.  
Q21 Does the structure contain >= 3 different 
types of functional groups  
  
Puts into Class III aliphatic compounds 
with >= 3 different types of functional 
groups (excluding polyesters and similar 
substances) 
Incorrect prediction from Q21 
(reported by the Toxtree developers): 
the acid and its sodium salt are 
incorrectly predicted to belong to 
different Cramer classes. According to 
Q4 a sodium salt should be treated as a 
free acid. 
Software  
This was recognised as a bug and fixed in Toxtree v. 2.1.0 and later. 
Q22 Is the substance a common component of 
food (C) or structurally related to a 
common component of food?  
Returns true if the query is isomorphic to 
one of the structures in the foodmol file 
See comments in Q1 Rulebase and software  
The foodmol file currently lists 108 natural food constituents (Toxtree 
v.1.6 and later).  
Q23 Is the substance aromatic? 
Q 23-26 deal with alicyclic substances  
- - 
Q24 Is the substance monocarbocycic with 
simple substituents? 
Is the substance monocarbocyclic 
(excluding cyclopropane or cyclobutane 
Class I misclassified as class II 
(Patlewicz et al. 2008), e.g. calcium 
cyclamate 
[Ca++].[O-]S(=O)(=O)NC1CCCCC1. 
Software  
Toxtree counted two rings instead of one. 
Alert software developer – IdeaConsult Ltd  
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
and their derivatives) with ring or aliphatic 
side chains,unsubstituted or containing only 
alcohol, aldehyde, side-chain ketone, acid, 
ester, or Na, K or Ca sulphonate or 
sulphamate, or acyclic acetal or ketal? 
 
[O-]S(=O)(=O)NC2CCCCC2 
Q25 Is the substance  
(a) a cyclopropane or cyclobutane with 
only the substituents mentioned in Q24 or  
(b) a mono- or bicyclic sulphide or 
mercaptan?  
- - 
Q26  - - 
Q27 Do(es) the ring(s) have any substituents? 
Q27-31 deal with aromatic compounds. 
- - 
Q28 Does the structure contain more than one 
aromatic ring?  
- - 
Q29 Is it readily hydrolysed to mononuclear 
residues? 
If YES, treat the individual aromatic 
mononuclear residues by Q30 and any 
other residue by Q19.  
- - 
Q30 Does it contain an aromatic ring with 
complex substituents? 
Disregarding ring hydroxy or methoxy does 
the ring bear substituents other than 1-5-
carbon aliphatic groups, either hydrocarbon 
or containing alcohol, ketone, aldehyde, 
carboxyl or simple esters that may be 
hydrolised to ring substituents of =5 
carbons?  
(If a simple ester that may be hydrolysed, 
treat the aromatic portion by Q.18 and the 
residue by Q19.)  
This should be answered NO if the ring 
bears only aliphatic groups of =5 carbons, 
which are either hydrocarbons containing 
the groups listed.If the ring bears any other 
Unclear rule  
Cut-off of 5 carbons should be 
reconsidered, and maybe set at 6.  
Example (Patlewicz et al. 2008): 
4-hexylresorcinol 
CCCCCCC1=C(O)C=C(O)C=C1 
misclassified as class II instead of I  
Example provided by EFSA: 
O=C(OCC)C1=CC=CC=C1OCC (ethyl 
4-ethoxybenzoate) gives class III.: ester 
hydrolysis results in the aromatic part 
and an ethanol. Ethanol is numbered as 
“Residue 2”: this Residue 2 get a 
classification of class II. Nevertheless, 
the aromatic part is predicted to be 
Clarification and possible rulebase revision and software implementation 
 
Redefine rule, test it with selected substances, and implement changes in 
future software release. 
Current implementation: With Q30, a simple ester, i.e. Ar-COO-R, where 
R is a 1-5-carbon aliphatic, triggers Yes, and is hydrolyzed, and the two 
portions go through Q31 and Q32.  
This is not correct, since the Cramer rule wants the Ar part of such ester 
to go to Q18, and the non-Ar part to Q19.  
Proposed correction:  
do not allow hydrolysis already in Q30  
(e.g. in the example provided by EFSA: Residue 2 / EtOH answers Yes 
to Q30, should go unhydrolised to Q31 and there be hydrolised (so that 
the Ar part goes to Q18, and the non-Ar part to Q19)  
 22
Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
substituents than those listed, the question 
should be answered YES and proceed to 
Q31  
class III, and so the entire compound 
gets assigned this class 
 
Q31 Is the substance an acyclic acetal or ester of 
substances defined in Q30? 
If YES, assume hydrolysis and treat the 
non-aromatic residues by Q19 and the 
aromatic residue by Q18.)  
This question is designed to see whether 
the substance would fit within the 
definition of Q30 if it were not an acetal, a 
ketal or an ester.In other words, would the 
substance carry only the groups listed in 
Q30.  
- - 
Q32 Does the substance contain only the 
functional groups listed in Q30, or their 
derivatives listed in Q31, but with any or 
all of the following:  
(a) a single fused non-aromatic carbocyclic 
ring  
(b) aliphatic substituent chains longer than 
5 carbon atoms, or  
(c) a polyoxyethylene [(-OCH2CH2-)x, 
with x = 4] chain either on the aromatic 
ring or on an aliphatic side chain?  
Part (a) is intended to allow simple 
derivatives of tetralin into class II while 
putting polycyclic compounds such as 
steroids ultimately into class III except 
those that may be normal food components. 
Part (b) allows compounds with permitted 
functional groups but longer side chains 
into class II instead of sending them 
eventually into class III.  
Part (c) puts short-chain polyoxyethylene 
derivatives of aryl compounds into class II 
rather than class III.  
In the question explanation: (c)a 
polyoxyethylene [(-OCH2CH2-)x, with 
x = 4] chain either on the aromatic ring 
or on an aliphatic side chain?  
 
Clarification  
While this restriction is implemented since the first Toxtree versions, the 
rule explanation should be clarified by saying 1<x<4 (and not x = 4).  
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
 
Q33 Does the substance bear on every major 
structural component at least one Na, K or 
Ca sulphonate or sulphamate for every 20 
or fewer carbon atoms, without any free 
primary amines except those adjacent to the 
sulphonate or sulphamate.  
Na,K,Ca sulphonate and sulphamate salts 
have a strong tendency to decrease toxicity 
by promoting solubility and rapid 
excretion. This is particularly noticeable, 
for example, with some of the food 
colourings. It is important that the 
substance bears sufficient sulphonate 
groups, including one on each major 
structural fragments into which the original 
compound might be metabolized. This 
question serves to steer sulphonated 
compounds except those with amines non-
adjacent to the sulphonate into a 
presumptively less toxic classification than 
the compounds would occupy if 
unsulphonated.  
 
Unclear rule 
Some class III substances (e.g. Na 5-
aminonaphthalene-2-sulphonate) are 
misclassified as class I (Patlewicz et al. 
2008). 
Toxtree also fails to assign as class I 
compounds where the sulphonate group 
is adjacent to a primary amine 
 
Software 
 
General 
comment 
 Would be good to have Toxtree set up 
to run the entire TTC tiered approach 
with one click – the software would 
determine if the chemical should be 
excluded, identify structural alerts 
(SAs) for genotoxicity and then 
determine the Cramer Class. It might 
be helpful to be able to determine the 
Cramer Class even if a chemical does 
have SA’s but there is a potential for 
mis-use if the user doesn’t realize that 
they have to consider SA’s before 
advancing to the Cramer Classes 
These suggestions have been implemented into the Toxtree plug-in for 
the Kroes TTC decision tree (Toxtree 2.1.0 and later) 
General 
comment 
 The monomethyl and monoethyl ether 
derivatives of ethylene glycol have 
Rulebase and software  
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Cramer 
question  
Rule definition and explanation Observation from literature or 
questionnaire 
Type of comment & proposed follow-up 
been shown to cause haematological 
effects in experimental animals and 
also to be teratogenic following 
exposure by oral and other routes (see 
review in ECETOC 1985). Thus, 
Phillips et al. (1978) suggested to put 
all glycol ethers including ethylene 
glycol monoethyl and monomethyl 
ethers into class II or III 
 
Phillips' suggestions could be implemented, but where (revise Q21?).  
  Review Cramer treatment of Class I 
outliers, e.g. acetone, phenols and 
methoxymethanol, which have low 
NOELs 
 
  It might be desirable to establish an 
international forum for agreeing 
changes to the Cramer scheme.  
 
Rulebase and software  
 
Footnote: Questions 40-43 refer to the Extended Cramer scheme 
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Appendix 3. Comparison of Cramer and ICH classifications for residual solvents in 
pharmaceutical products 
 
In a recent study by Naven & Derzi (2011) 01, the safety thresholds derived by Munro using the Cramer 
scheme were compared with the ICH classification for residual solvents in pharmaceutical products 
(ICH, 2011). Using a test set of 59 ICH solvents and 9 non-classified compounds (internally 
evaluated), the ability of the Cramer decision tree to discriminate between low risk and high risk 
compounds was assessed (Toxtree 2.1.0, Cramer rules with extension plug-in). The authors concluded 
that the Cramer scheme, while requiring updating and refining to reflect today’s chemical space, 
overall was effective for distinguishing these compounds classes. However, when the structural feature 
contributions to low risk- and high risk-class discrimination were determined, through a Dragon 
Descriptor Function Group Count analysis, only a limited number of structure-toxicity relationships 
could be found. This was attributed to the complexity and multi-factorial progression of chronic 
toxicity and the statistical limitation of NOEL values as toxicological endpoint (e.g. the NOEL value is 
affected by the choice of test doses). Furthermore, the Cramer decision tree pathway for each 
compound was analysed to identify the Cramer rules which were reflective of toxicity, from which it 
was concluded that broad rules were more useful to make the high- and low-toxicity distinction. The 
following rules were considered to be most useful:  
 
High toxicity:  
• Questions identifying the presence of uncommon elements 
• Questions identifying the presence of reactive functional groups 
• Answer NO to Q33: does the substance bear a sufficient number of SO3 groups? (Na,K,Ca 
sulphonate and sulphamate salts have a strong tendency to decrease toxicity by promoting 
solubility and rapid excretion). 
 
Low toxicity:  
• Q1 natural body constituent 
• Q22 food constituent 
• Answer NO to Q18 (which examines the terpenes and later the open-chain and mononuclear 
substances to determine whether they contain certain structural features generally thought to be 
associated with some enhanced toxicity (e.g. heterocycles, polyaromatic, etc)  
 
Five compounds were reported to be Cramer scheme Class 1 outliers (i.e. having low NOELs): 
including acetone, an alkoxy ethanol, a poly-ether alkane, 2,6-dimethyl phenol and an aryl,alkyl 
secondary alcohol, pointing to possible improvements of the scheme. 
 
                                                 
1 The authors are grateful to Russell Naven (Pfizer) for his comments and for providing a copy of the poster presentation 
(Naven & Derzi, 2011).  
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Appendix 4. Analysis of the bodymol (body components) and foodmol (food constituents) 
compounds in Toxtree 
 
Summary 
Cramer rules #1 and #22 depend on user-defined lists of compounds, which are normal constituents of 
the body or common components of food, respectively. The user-defined lists are encoded in the 
bodymol.sdf and foodmol.sdf files, which can be modified (extended, reduced, removed) based on 
expert judgement. 
In this study, we explored how the Cramer scheme would classify these substances if the look-up lists 
(bodymol and foodmol) were not taken into account. This was carried out by processing the bodymol 
and foodmol structures in Toxtree 1.6, using both the unmodified form of the Cramer rulebase, and a 
modified form in which the look-up files were replaced with empty (structure-free) files. In addition, 
we investigated how the Benigni-Bossa scheme would classify the same substances in terms of their 
predicted genotoxic potential.  
A total of 548 compounds, including 440 bodymol and 108 foodmol compounds, were analysed. The 
results show that a high proportion (75%; 409 out of 548) of the compounds in the look-up lists are 
potentially of medium (Class II) or high (Class III) concern as classified by the Cramer scheme, 
whereas 139 compounds (25%) are of low concern. Of the 409 compounds classified in Cramer 
Classes II or III, 114 compounds are predicted as genotoxic by the Benigni-Bossa module for 
carcinogenicity and mutagenicity (Benigni et al, 2008). Thus, in the context of an overall TTC 
assessment scheme, such as the Kroes decision tree (Kroes et al. 2004), these 114 compounds would 
be removed in a pre-Cramer step, and would therefore not receive a Cramer classification. In addition, 
the Benigni-Bossa rulebase also predicts 10 of 139 Cramer Class I compounds as genotoxic. The pre-
screening by the Benigni-Bossa rulebase would therefore result in 124 compounds being removed 
from further consideration, while 424 compounds would enter the Cramer scheme. In this further 
analysis, 12/13 compounds resulted in class II/III respectively, which are all foodmol compounds. 
 
Method 
 
To create the modified version of the Cramer rulebase, we used Toxtree 1.6, and not later versions, 
because in v. 2.1.0 and later the bodymol and foodmol sdf files are not stored in the application folder 
as they are in 1.6, but they are packaged inside one of the Toxtree-Cramer jar files which are extracted 
into a temporary folder when the Cramer rulebase is applied. This means that the bodymol and 
foodmol files cannot be easily manipulated by the user in version 2.2.0. The bodymol and foodmol 
files can also be obtained from Sourceforge: 
  
Bodymol file: 2Uhttp://toxtree.svn.sourceforge.net/viewvc/toxtree/bodymol.sdf?view=log 
Foodmol file: 2Uhttp://toxtree.svn.sourceforge.net/viewvc/toxtree/foodmol.sdf?view=log 
 
A combined file containing 548 bodymol and foodmol substances was analysed in: 
a) Toxtree 1.6 (unmodified) 
b) Toxtree 1.6 (modified, without look up lists), in which the bodymol and foodmol files were 
emptied.  
 
The 548 bodymol and foodmol substances were also assessed for their potential genotoxicity by using 
the Benigni-Bossa module for carcinogenicity and mutagenicity in Toxtree, including the embedded 
QSAR models. In this case, the latest downloadable version of the software, Toxtree 2.2.0 (October 
2010), was used, since it includes several bug fixes compared with Toxtree 1.6. 
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In applying the Benigni-Bossa rulebase, the results were interpreted as follows: if any of the BB 
QSAR models were applicable, and if at least one QSAR model gave a positive outcome (i.e. 
"Potential S. typhimurium TA100 mutagen based on QSAR", or "Potential carcinogen based on 
QSAR"), a positive prediction (1) was assigned, whereas if all QSAR results were negative ("Unlikely 
to be a S. typhimurium TA100 mutagen based on QSAR" or "Unlikely to be a carcinogen based on 
QSAR") a negative outcome (0) was assigned. If none of the QSAR models were applicable, the 
outcome of the SA analysis was considered. 
 
Results – Cramer analysis 
The outcome of applying the original Cramer rulebase and the Cramer rulebase with Extensions in 
Toxtree 1.6 is summarised in Table 2. 
 
Table 2. Cramer classifications for 548 common body or food components  
 
 Toxtree 1.6 / Original 
Cramer rules (unmodified) 
Toxtree 1.6 / Cramer rules 
with Extension (unmodified) 
Toxtree 1.6 / Cramer with 
Extension plug-in (modified, 
without look up lists) 
 class I class II class III class I class II class III class I class II class III 
Bodymol (440 
compounds) 
439 0 1* 439 0 1* 88 13 339 
Foodmol (108 
compounds) 
76 20 12 76 16 16 51 5 52 
Total (548 
compounds) 
515 20 13 515 16 17 139 18 391 
*This is an error, due to an incorrect structure for protoheme in the bodymol file 
 
Unmodified Cramer scheme 
 
• When the unmodified Cramer scheme is applied to bodymol compounds, all of them are 
expected to be classified in Class I (since they trigger a 1Y response). In practice, however, 
protoheme triggered the following classification: 1N,2N,3Y,4N (class 3). This is an error, due 
to an incorrect structure for protoheme in the bodymol file (bodymol.sdf; #221). 
• When the unmodified Cramer scheme is applied to the foodmol compounds, any hazard class 
(I, II or III) can result. This is because, in contrast to the assessment of the bodymol file, which 
is the first question and always verified, the Cramer scheme does not set verification of the 
foodmol file (Q22) as mandatory. Even when the compound is present in the foodmol.sdf, the 
flow of the questions may not pass through Q22. Several different decision-tree evaluation 
patterns can therefore result, and the final classification vary according to the chemical 
structure:  
o The analysis stops when answering to Q4 since the compound contains elements 
outside of the common organic subset, as defined in Q4. In this case, Class III is 
assigned, and Q22 is not verified. For example, "1N,2N,3Y,4N" (saccharin).  
o The analysis takes a pathway which does not include Q22 and therefore foodmol.sdf is 
not verified. For example, "1N,2N,3N,5N,6N,7Y,8N,10N,11Y,33N"  (folic acid). 
o The analysis involves hydrolysis or other metabolic reactions. For example: 
"1N,2N,3N,5N,6N,7N,16N,17N,19N,23Y,27Y,28N,30Y(31N,32Y)(31N,32N,22N,33" 
(aspartame) and "1N,2N,3Y,4Y,40N,41N(7Y,8N,10N,11N,12Y,13Y,14N,22N,33N)" 
(vitamin B6). In this case, starting from the rule where the reaction occurs (i.e. 30Y for 
aspartame), the subsequent analysis is performed not on the original query compound, 
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but on each of the reaction products, which is verified against foodmol.sdf, and might 
not be in the list (22N).   
• When the unmodified Cramer scheme was applied to the 108 foodmol compounds, 20 
compounds resulted of intermediate concern (Class II), of which 16 triggered a positive answer 
to Q22, while the remaining four had a more complex classification pathway. None of the 
original query foodmol compounds had a 22N result, indicating that no structural errors were 
present in foodmol.sdf (22N occurs for one of the hydrolysis products of aspartame). Of the 20 
Class II foodmol compounds with the original Cramer scheme, four resulted in Class III when 
the Cramer rules with extensions plug-in (unmodified) was used instead of the original scheme, 
owing to a positive answer to either question 42 (dimethylpyrazine, maltol, methylpyrazine) or 
question 43 (cystine) of the extended rulebase (Table 3). 
• Interestingly, 44 foodmol compounds would be classified as low concern (Class I) following 
matching with the bodymol list (1Y). 
 
Modified (without look-up lists) Cramer rulebase with extensions  
 
• When the modified version (without look-up lists) of the Extended Cramer scheme was 
applied, Class II/III classifications were obtained for 352 bodymol substances (cf. 1 compound 
in the unmodified version of the scheme) and for 57 foodmol compounds (cf. 32 compounds in 
the unmodified version of the scheme). 
 
Table 3. Foodmol compounds classified in Class II by the original Cramer scheme that 
reclassifed in Class III by the Extended Cramer rulebase in Toxtree 1.6 
 
Compound Original Cramer scheme result Extended rulebase result  
cystine 1N,2N,3N,5N,6N,7N,16N,17N,19Y,20N,22Y 1N,2N,3N,43Y 
dimethylpyrazine 1N,2N,3N,5N,6N,7Y,8N,10N,11N,12Y,13Y,14N,22Y 1N,2N,3N,43N,5N,6N,42Y 
maltol 1N,2N,3N,5N,6N,7Y,8N,10N,11N,12N,22Y 1N,2N,3N,43N,5N,6N,42Y 
methylpyrazine 1N,2N,3N,5N,6N,7Y,8N,10N,11N,12Y,13Y,14N,22Y 1N,2N,3N,43N,5N,6N,42Y 
 
 
Results – Benigni-Bossa analysis 
 
For the combined dataset of 548 bodymol/foodmol compounds: 
 
• the Benigni-Bossa QSAR models were applicable to 17 compounds (QSAR6/8 for 15 aromatic 
amines, and QSAR13 for 2 α,β-unsaturated aldehydes), of which 11 gave a positive 
mutagenic/carcinogenic prediction and 6 a negative prediction; 
• 127 compounds triggered a SA for genotoxic carcinogenicity; 
• no SA for non-genotoxic carcinogenicity was fired. 
 
The breakdown of the results obtained with the Benigni-Bossa module in Toxtree according to Cramer 
classification is given in Table 4. 
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Table 4. Cramer and Benigni-Bossa classifications of the bodymol and foodmol compounds 
(Toxtree 1.6 / Cramer with Extension plug-in, without look-up lists vs. Toxtree 2.2.0 / 
Benigni-Bossa rulebase) 
 
Bodymol and 
foodmol 
compounds 
Positive prediction 
in at least one 
Benigni-Bossa 
QSAR model 
Negative prediction 
in at least one 
Benigni-Bossa 
QSAR model 
Benigni-Bossa Structural 
Alert(s) for genotoxic 
carcinogenicity 
Overall prediction: 
potentially genotoxic  
class I (139 
compounds) 
0 1 11 10 
class II (18 
compounds) 
0 0 3 3 
class III (391 
compounds) 
11 5 113 111 
 
 
In Table 4, it can be seen that: 
 
• 114 Class II/III compounds are potential carcinogens based on the Benigni-Bossa rulebase as 
implemented in Toxtree 2.2.0; 
• 10 Class I compounds triggered a Benigni-Bossa Structural Alert for genotoxic carcinogenicity. 
These compounds are 2 foodmol compounds, menadione (vitamin K3) and vanillin, and 8 
bodymol compounds: 3,4-dihydroxyphenyl)acetaldehyde, succinate, 4-aminobutanal, 4-
methylpentanal, acetaldehyde, glyoxylate, glyceraldehyde and malonate.  
 
It has to be noted that SAs represent a first approximation, or ‘coarse-grain’ approach to SAR analysis, 
while QSAR models are fine-tuned estimations. The current QSAR models within the Benigni-Bossa 
rulebase in Toxtree only apply to a limited number of compound classes (aromatic amines and α,β-
unsaturated aldehydes, with restrictions). In fact, only one (cis-9-retinal) out of 139 Class-I compounds 
were suitable for the Benigni-Bossa QSAR analysis. Cis-9-retinal was predicted as "unlikely to be a 
Salmonella mutagen carcinogen based on QSAR" (QSAR13), while the α,β unsaturated carbonyls SA 
for genotoxic carcinogenicity was triggered.  
 
Results – Combined application of Benigni-Bossa and Cramer rules 
 
In an overall TTC assessment scheme, such as the one proposed by Kroes et al (2004), rules for the 
prediction of genotoxic potential would be applied before the Cramer rules, with the consequence that 
potentially genotoxic compounds re associated with a lower TTC value of 0.15 μg/day. Table 5 shows 
the outcomes of applying the Benigni-Bossa and Cramer classification schemes in sequence. 
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Table 5. Results obtained by the stepwise application of the Benigni-Bossa and Cramer (with 
extensions) rulebases to 548 bodymol and foodmol compounds 
 
No of compounds 
entering step 
Step 1 
Predicted genotoxic 
Step 2 
Cramer class I 
Step 2 
Cramer class II 
Step 2 
Cramer class III 
     
548 124 N/A N/A N/A 
424 (original Cramer 
with look-up lists) 
N/A 399 12 13 
424 (modified Cramer 
without look-up lists) 
N/A 129 15 280 
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